Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00448942 · ClinicalTrials.gov registry record
The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections
A clinical trial, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- Completed
- Registry status
- 5,300
- Enrollment target
NCT00448942 is a clinical trial that has completed, run by Hunter Holmes Mcguire Veteran Affairs Medical Center. The registered enrollment target is 5,300 participants.
The verdict
NCT00448942 has completed, sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center.
- COMPLETED
- Registry status
- 5,300 participants
- Enrollment target
Study Summary
The purpose of this study was to determine if the use of daily chlorhexidine bathing would decrease the incidence of MRSA and VRE colonization and healthcare associated Bloodstream Infections (BSI) among Intensive Care Unit (ICU) patients.
Interventions
- BEHAVIORAL Daily bathing with Chlorhexidine based product
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,300 participants |
| Start Date | 2004-11 |
| Est. Completion | 2006-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00448942
The ClinicalTrials.gov registry entry for NCT00448942 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Daily bathing with Chlorhexidine based product is the first listed.
NCT00448942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00448942 about?
NCT00448942 is a clinical study titled "The Impact of Chlorhexidine-Based Bathing on Nosocomial Infections". The purpose of this study was to determine if the use of daily chlorhexidine bathing would decrease the incidence of MRSA and VRE colonization and healthcare associated Bloodstream Infections (BSI) among Intensive Care Unit (ICU) patients.
What is the current status of trial NCT00448942?
This trial is currently completed. The enrollment target is 5,300 participants. The study started on 2004-11. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00448942?
The interventions under investigation include: Daily bathing with Chlorhexidine based product (BEHAVIORAL).
Who is sponsoring clinical trial NCT00448942?
This trial is sponsored by Hunter Holmes Mcguire Veteran Affairs Medical Center, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.